Jump to navigation
Melbourne study reassures.
It leads to cartilage loss with no significant improvement in pain.
First, the recommendation ‘use sparingly’ is nonsensical and has no value.
It's the first population-based incidence study.
In the worst case scenario, growth is stunted by 1.2cm, review shows.
Recognition that asthma is not a single disease is leading to promising collaborative research on macrolide therapy...
NSW pharmacist supplied 46,888 pseudoephedrine-based products to cash-paying customers over two years.
Local anaesthetic alone is just as effective, study finds
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.